
Kepley BioSystems: A life sciences start-up in Greensboro, NC, innovating in nanoscience and nanoengineering.
Kepley BioSystems is a life sciences startup founded in Greensboro, North Carolina, and operates out of Gateway University Research Park in collaboration with the Joint School of Nanoscience and Nanoengineering. The company's core mission is to innovate in the fields of nanoscience and nanoengineering to address critical ecological and medical challenges. Kepley BioSystems focuses on sustainable practices, particularly in the use of the Atlantic horseshoe crab's blue blood for endotoxin testing in the medical industry. Their innovative approaches aim to ensure the viability and well-being of this ecologically important species while meeting industrial demands.
Notable affiliated people include researchers and scientists from the Joint School of Nanoscience and Nanoengineering. Kepley BioSystems has garnered attention for its pioneering methods in horseshoe crab husbandry and bleeding techniques, which have significant implications for both ecological conservation and medical testing. The company’s impact is reflected in its contributions to sustainable practices in biotechnology, potentially setting new standards for industry operations that balance ecological preservation with technological advancement.
Companies similar to Kepley BioSystems include Keystone Bio, NightHawk Biosciences, Capra Biosciences and SciKon Innovation.
Kepley BioSystems was founded in 2013.
Kepley BioSystems' headquarters is located in Greensboro, NC, US.
Kepley BioSystems' most recent funding round was for $1M (USD) in December 2022.
As of Dec 13, 2022, Kepley BioSystems has raised a total of $2.6M (USD).
Kepley BioSystems has 5 employees as of Feb 4, 2024.
Capra Biosciences